CSIMarket
 


Cytodyn inc   (CYDY)
Other Ticker:  
 

Cytodyn Inc 's Working Capital Ratio

CYDY's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




CYDY Working Capital Ratio (Aug 31 2021)
I. Quarter
(May 31 2021)
IV. Quarter
(Feb 28 2021)
III. Quarter
(Nov 30 2020)
II. Quarter
(Aug 31 2020)
I. Quarter
Y / Y Current Liabilities Change 60.4 % 199.54 % 214.26 % 289.64 % 231.32 %
Y / Y Current Assets Change 28.68 % 251.86 % 350.59 % 3930.44 % 2396.13 %
Working Capital Ratio MRQ 0.84 0.97 0.86 1.13 1.05
Overall Ranking # # # # #
Seq. Current Liabilities Change -8.04 % 3.44 % 11.35 % 51.43 % 71.74 %
Seq. Current Assets Change -20.68 % 16.89 % -15.24 % 63.75 % 116.9 %



Working Capital Ratio first quarter 2021 Comment
Despite sequential decrease in Current Liabilities, Working Capital Ratio detoriated to 0.84 below company average Working Capital Ratio.

Within Biotechnology & Pharmaceuticals industry 215 other companies have achieved higher Working Capital Ratio than Cytodyn Inc in first quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is CYDY most successful ?
Working Capital Ratio CYDY on the trailing twelve month basis
Working Capital Ratio first quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 216
Healthcare Sector # 882
Overall Market # 4317


Working Capital Ratio Statistics
High Average Low
5.11 1.12 0.11
(Feb 29 2016)  




Financial Statements
Cytodyn Inc 's Current Liabilities $ 123 Millions Visit CYDY's Balance sheet
Cytodyn Inc 's Current Assets $ 103 Millions Visit CYDY's Balance sheet
Source of CYDY's Sales Visit CYDY's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingAug 31 2021, within Biotechnology & Pharmaceuticals Industry Working Capital RatioAug 31 2021 MRQ Current AssetsAug 31 2021 MRQ Current Liabilities
Biogen Inc   1.70 $ 7,162.300  Millions$ 4,211.600  Millions
Cytodyn inc   0.84 $ 102.786  Millions$ 122.582  Millions
Cell Medx Corp   0.24 $ 0.101  Millions$ 0.427  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CONN's Profile

Stock Price

CONN's Financials

Business Description

Fundamentals

Charts & Quotes

CONN's News

Suppliers

CONN's Competitors

Customers & Markets

Economic Indicators

CONN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071